Episode 12 covers significant Series A and B funding developments, starting with Nscale's impressive $155 million Series A round, highlighting their sustainability initiatives and insights from CEO Joshua Payne on the company's unique value and future plans. The episode also explores Nscale's global partnerships and the launch of their public cloud service. Pixxel's $24 million Series B extension is discussed, focusing on their hyperspectral satellite technology and AI-driven Earth Observation platform, Aurora. Additionally, Citryll's €85 million Series B funding is examined, including the introduction of new board members. The episode concludes with a wrap-up and follow-up information.

(0:00) Welcome to The Series A & B Investor Daily Brief

(0:13) Nscale secures $155 million in Series A funding and sustainability focus

(2:19) Nscale CEO Joshua Payne on company’s unique value and future plans

(4:07) Nscale’s global partnerships and public cloud service launch

(5:52) Pixxel closes $24 million in Series B extension and hyperspectral satellite tech

(7:37) Pixxel’s AI-driven Earth Observation platform Aurora

(8:57) Citryll raises €85 million in Series B and introduces new board members

(11:45) Episode wrap-up and follow-up information

Episode 11 dives into today's top Series A and B funding stories, featuring Heirloom's impressive $150 million Series B round, highlighting their technological advancements and growth plans with insights from their CEO. The episode also explores HappyRobot's $15.6 million Series A funding, focusing on their AI-driven logistics solutions and the CEO's vision for the future. Additionally, Nua Surgical's €6.5 million Series A investment is discussed, emphasizing their SteriCISION innovation and future strategies. The episode concludes with a wrap-up and encourages listeners to follow for more updates.

(0:00) Welcome to The Series A & B Investor Daily Brief

(0:15) Today's top Series A and B funding stories

(0:24) Heirloom's $150 million Series B: Technology, Growth, and CEO Insights

(2:54) HappyRobot's $15.6 million Series A: AI in Logistics and CEO's Vision

(5:21) Nua Surgical's €6.5 million Series A: SteriCISION Innovation and Future Plans

(7:51) Wrap-up and follow for updates

Episode 10 delves into notable Series A and B funding updates, beginning with LIS Technologies, Enterpret, and Orbite's Series A accomplishments. The episode then transitions to Series B funding, featuring Sage, Sollis Health, and AMPECO's recent developments. Additionally, the episode highlights substantial Series B rounds for Nuvig Therapeutics and Heirloom, showcasing their strategic growth plans and impact.

(0:00) Welcome to The Series A & B Investor Daily Brief

(0:14) Series A funding highlights: LIS Technologies, Enterpret, and Orbite

(5:38) Series B funding updates: Sage, Sollis Health, and AMPECO

(11:02) Nuvig Therapeutics and Heirloom's substantial Series B rounds

(14:15) Closing remarks and follow instructions

Episode 9 provides insights into recent Series A and B funding rounds, starting with KPay's Series A funding and their market expansion strategies. The episode highlights HappyRobot's Series A funding, focusing on their innovative AI logistics solutions. Enterpret's Series A funding is discussed, emphasizing the impact of their platform. Additionally, Soda Health's Series B funding is explored, detailing their future strategy. The episode concludes with Heirloom's Series B funding, which underscores their efforts in addressing climate change.

(0:00) Welcome to The Series A & B Investor Daily Brief

(0:14) KPay's Series A funding and market expansion insights

(2:42) HappyRobot's Series A funding and AI logistics innovation

(5:07) Enterpret's Series A funding and platform impact

(7:58) Soda Health's Series B funding and future strategy

(10:30) Heirloom's Series B funding and climate impact

(12:43) Closing remarks and call to action

Episode 8 covers the latest Series A and B funding developments, starting with KPay Group and Acceleron Fusion's significant Series A achievements. The episode then highlights Nurture Boss and VIOLETTE_FR, both celebrating successful Series B investments. Additionally, Soda Health and Yurts announce major Series B funding rounds, contributing to their growth trajectories. The episode concludes with 9fin's substantial Series B investment, marking another key development in the funding landscape.

(0:00) Welcome to The Series A & B Investor Daily Brief

(0:14) Today's top Series A and B funding stories

(0:22) KPay Group and Acceleron Fusion secure significant Series A funding

(3:28) Nurture Boss and VIOLETTE_FR celebrate Series B investments

(6:11) Soda Health and Yurts announce major Series B funding rounds

(9:14) 9fin secures a substantial Series B investment

(12:18) Wrap up and closing remarks

Episode 7 delves into recent Series B funding rounds, starting with Cradle's $73 million funding, highlighting their future plans. The episode also covers 9fin's $50 million Series B, focusing on their strategic initiatives. Tembo's £14 million Series B funding is discussed, emphasizing their market strategy. Additionally, Archway Software's Series B round is explored, shedding light on their growth trajectory.

(0:00) Welcome to The Series A & B Investor Daily Brief

(0:14) Cradle’s $73 million Series B funding and future plans

(2:07) 9fin’s $50 million Series B funding and strategic plans

(4:16) Tembo’s £14 million Series B funding and market strategy

(7:07) Archway Software’s Series B round and growth trajectory

(9:35) Closing remarks and follow instructions

Episode 6 explores recent Series A and B funding rounds, beginning with Agentio's Series A funding, which includes future plans and executive insights. The episode also examines Neuron7.ai's Series B funding, highlighting their expansion strategies. Additionally, Range's Series B funding is discussed, offering a growth outlook enriched by an investor's perspective.

(0:00) Welcome to The Series A & B Investor Daily Brief

(0:14) Agentio's Series A funding and future plans with executive insights

(3:44) Neuron7.ai's Series B funding and expansion strategies

(6:08) Range's Series B funding and growth outlook with investor perspective

(8:43) Conclusion and call to action

Episode 5 explores a diverse array of Series A funding rounds, starting with Allink Biotherapeutics securing $42 million, providing insights into their biotherapeutic advancements. Celosia Therapeutics' Series A funding is highlighted for its focus on ALS gene therapy. The episode also features Constrafor's impressive $264 million Series A, driving innovation in the construction industry. Additionally, Roon's Series A funding is covered, emphasizing expansion in women's health information, alongside Doron Therapeutics' Series A earmarked for Phase 3 clinical studies in osteoarthritis.

(0:00) Welcome and introduction

(0:16) Allink Biotherapeutics' $42 million Series A and company insights

(3:21) Celosia Therapeutics' Series A funding for ALS gene therapy

(5:04) Constrafor's $264 million Series A and construction industry innovation

(8:19) Roon's Series A funding and expansion in women's health information

(11:34) Doron Therapeutics' Series A for Phase 3 clinical studies in osteoarthritis

(14:02) Episode wrap-up and call to action

Episode 4 delves into notable Series A and B funding rounds. It highlights Neuron7.ai's Series B funding backed by Battery Ventures, showcasing the growing interest in AI-driven solutions. The episode also covers Inversion's Series A success, complemented by a prestigious SpaceWERX STRATFI award, signaling a promising future in space technology.

(0:00) Welcome to The Series A & B Investor Daily Brief

(0:13) Neuron7.ai Series B funding and Battery Ventures' backing

(1:49) Inversion's Series A success and SpaceWERX STRATFI award

(3:21) Wrap-up and call to follow the podcast

Episode 3 delves into key Series A and B funding rounds, spotlighting PointFive, Grey Market Labs, and emma in the Series A category. It also highlights significant Series B funding for Range and Plantible Foods, alongside Fresho's $17 million Series B milestone. The episode concludes with Elchemy's successful Series A announcement.

(0:00) Introduction to the Series A & B Investor Daily Brief

(0:14) Key Series A funding rounds: PointFive, Grey Market Labs, and emma

(7:11) Key Series B funding rounds: Range and Plantible Foods

(13:55) Fresho's $17 million Series B milestone

(15:45) Elchemy's Series A success

(18:28) Closing remarks and call to action